Omalizumab-A Review.

Article Details

Citation

Copy to clipboard

Godse K, Mehta A, Patil S, Gautam M, Nadkarni N

Omalizumab-A Review.

Indian J Dermatol. 2015 Jul-Aug;60(4):381-4. doi: 10.4103/0019-5154.160490.

PubMed ID

26288408 [ View in PubMed

]

Abstract

Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE). The US FDA has approved this molecule for chronic urticaria.

DrugBank Data that Cites this Article

Drugs

Omalizumab

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Omalizumab	High affinity immunoglobulin epsilon receptor subunit alpha	Protein	Humans	Yes	Inhibitor	Details